Evidence map›Paper›PMID 35015088›Full record

ArticleHerz2022

[Cardiogenic shock complicating myocardial infarction].

Karl Werdan, Markus Wolfgang Ferrari, Roland Prondzinsky, Martin Ruß

Abstract read
PubMed Publisher
In one paragraph

Article in Herz, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. [Core curriculum of intensive care and emergency medicine in internal medicine].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2025
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Karl WerdanUniversitätsklinik und Poliklinik für Innere Medizin III, Universitätsklinikum Halle (Saale), Martin-Luther-Universität Halle-Wittenberg, Ernst-Gruber-Str. 40, 06120, Halle (Saale), Deutschland. karl.werdan@medizin.uni-halle.de.
Markus Wolfgang FerrariKlinik für Innere Medizin I, Helios Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Deutschland.
Roland ProndzinskyKlinik für Innere Medizin I, Carl-von-Basedow-Klinikum Saalekreis gGmbH, Bereich Merseburg, Merseburg, Deutschland.
Martin RußInternisten am Marktplatz, Traunstein/Belegkardiologie Traunstein, Traunstein, Deutschland.
Asklepios Neurologische Klinik Falkenstein · DEHelios Dr. Horst Schmidt Kliniken Wiesbaden · DEUniversity Hospital in Halle · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiogenic shock as a complication of myocardial infarction (5-10%) increases the mortality of uncomplicated myocardial infarction from less than 10% to 40%. This is due to the development of multiple organ dysfunction syndrome triggered by the extensive shock-induced impairment of organ perfusion. Therefore, guideline-based treatment should not only be restricted to reopening of the occluded coronary artery and management of complications of the infarction: important for survival are also guideline-driven optimization of organ perfusion by inotropic and vasoactive substances and, with well-defined indications, by temporary mechanical circulatory support but not by intra-aortic counterpulsation. Equally important, however, are shock-specific intensive care measures to prevent or attenuate organ dysfunction, such as lung protective ventilation in cases where ventilation is obligatory.

Indexed as

Myocardial InfarctionShock, CardiogenicHumansIntra-Aortic Balloon PumpingMultiple Organ FailureGuidelinesIntra-aortic balloon counterpulsationMultiple organ failurePercutaneous coronary interventionTemporary mechanical support

Identifiers

PMID35015088
OpenAlexW4205241974

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.